JoyceDFingerothMD
Infectious Disease • Worcester, MAAssociate Professor of Medicine, Beth Israel Deaconess Medical Center
Dr. Fingeroth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 508-856-2456- Is this information wrong?
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1977 - 1980
New York University School of MedicineClass of 1977
Certifications & Licensure
MA State Medical License 1980 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsThe association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study.Yujing Jan Heng, Susan Love, Jessica Clague DeHart, Joyce D Fingeroth, Gerburg M Wulf> ;Breast Cancer. 2022 Jul 1
- 2 citationsSerotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein-Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lym...Elham Ahmadi, Mehrdad Ravanshad, Jun Xie, Rajesh Panigrahi, Sandeep Jubbal, Santosh Kumar Guru, Gao Guangping, Mazyar Ziyaeyan, Joyce D. Fingeroth> ;Virology Journal. 2021 Nov 18
- 12 citationsComplete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and DexamethasoneJames P Dugan, Bradley M. Haverkos, Linda Villagomez, Ludmila Katherine Martin, Mark E. Lustberg, John T. Patton, Marisa F. Martin, Ying Huang, Gerard J. Nuovo, Fengti...> ;Clinical Cancer Research. 2018 Jul 15
- Join now to see all
Press Mentions
New Clues to Epstein-Barr VirusFebruary 21st, 2013
Grant Support
- Formins (FHOS) In Cd21-Mediated Signaling &Virus EntryNational Institute Of Allergy And Infectious Diseases2005–2009
- The Structural Basis Of EBV Attachment: CD21 &Gp350/220National Institute Of Dental &Craniofacial Research2004–2005
- Treatment Of Virus Associated Proliferative DisordersNational Cancer Institute1999–2003
- Design Of Ebvtk Substrates To Eradicate EBV+ TumorsNational Cancer Institute2001
- Pathogenesis Of Oral Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1999–2001
- Human Herpesvirus 8 Infection Of Dermal Microvascular Endothelial CellsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999
- Pathogenesis Of Oral Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1997–1998
- Putative Murine Complement Receptor Type 2National Institute Of Allergy And Infectious Diseases1988–1992
- Cloning &Characterization Of The EBV (C3D) ReceptorNational Cancer Institute1988
- Cloning And Characterization Of The EBV (C3D) ReceptorNational Cancer Institute1985–1987
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
UMass Memorial Medical CenterWorcester, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
